Comparing SSRI Treatment Costs for Depression Using Retrospective Claims Data: The Role of Nonrandom Selection and Skewed Data
- 1 May 2000
- journal article
- Published by Elsevier in Value in Health
- Vol. 3 (3) , 208-221
- https://doi.org/10.1046/j.1524-4733.2000.33001.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilizationStatistics in Medicine, 1998
- Cost implications of initial antidepressant selection in primary care.PharmacoEconomics, 1998
- Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysisJournal of Affective Disorders, 1998
- Antidepressant Selection and Use and Healthcare ExpendituresPharmacoEconomics, 1998
- Channeling of Three Newly Introduced Antidepressants to Patients Not Responding Satisfactorily to Previous TreatmentJournal of Clinical Psychopharmacology, 1997
- Initial Antidepressant Choice in Primary CareJAMA, 1996
- A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary careJournal of Affective Disorders, 1996
- Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance OrganizationJournal of International Medical Research, 1995
- Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depressionCurrent Therapeutic Research, 1995
- Cost-effectiveness comparisons using “real world” randomized trials: The case of new antidepressant drugsJournal of Clinical Epidemiology, 1995